It is likely that the Professional who is not familiar with respiratory pathologies will find the apprehension of the concepts expressed in this kind of Tower of Babel of pathologies extremely confusing. The inexorable limitation that these produce in the quality of life of the affected patients is indisputable, as well as the enormous the economic cost that they originate in the productive and health systems. Nevertheless, a simplification -perhaps exaggerated- limits its management to prevention (impossible in genetically determined cases, and highly unlikely in the socioeconomic conditions of those who suffer from them), and similar treatments (both in their poor results and in the magnitude of side effects), which -in many cases- will lead to the unlikely lung transplant. The therapeutic proposal with inhaled ibuprofen comes to provide a simple and economical alternative to add to this countless nosological entities.